Journal of Medical Virology

Article	Citations
Aggregation of high‐frequency RBD mutations of SARS‐CoV‐2 with three VOCs did not cause significant antigenic drift	688
	453
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters	450
Exploring the Role of EBV Infection in EBV‐T/NKLPD With EBV Capture Technology Based on Single‐Cell RNA Sequencing	397
Molecular Epidemiology, Transmission, and Evolution of Rubella Virus Circulating in Tianjin, China, Between 2009 and 2020	264
Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association	247
Global estimates on the reports of vaccine‐associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database	240
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study	217
Torque teno virus viral load predicts SARS‐CoV‐2 vaccine response in kidney transplant recipients	198
Viral RNA capping: Mechanisms and antiviral therapy	195
Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform	190
Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers	187
Epstein‐Barr Virus Infection Presenting With Acute Gastrointestinal Involvement. Report of Two Cases of Epstein‐Barr Virus Colitis in Kidney‐Transplant Recipients and Scoping Review of the Literature	174
The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials	167
Assessment of immunity against Yellow Fever virus infections in northeastern Nigeria using three serological assays	162
A case of congenital human cytomegalovirus infection with placental and pulmonary calcification despite presence of intrauterine IgG	154
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B	146
Exploring the dynamics of the 2022 mpox outbreak in Canada	131
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections	129
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma	124
Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain	120
Monkeypox virus: A sexual transmission and beyond	115
Langat virus inhibits the gp130/JAK/STAT signaling by reducing the gp130 protein level	114
Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities	110
Nonpharmaceutical interventions reduce the incidence and mortality of COVID‐19: A study based on the survey from the International COVID‐19 Research Network (ICRN)	110

Comment on Limitations of “Assessing Herpes Zoster Vaccine Efficacy in Patients With Diabetes: A Community‐Based Cohort Study”	106
Mucosal‐associated invariant T cells: A cryptic coordinator in HIV‐infected immune reconstitution	105
Pityriasis rosea during COVID‐19: Pathogenesis, diagnosis, and treatment	105
Factors associated with dexamethasone efficacy in COVID‐19. A retrospective investigative cohort study	101
COVID‐19 vaccination and autoimmunity: Do we need more evidence?	101
ADAM9: A regulator between HCMV infection and function of smooth muscle cells	101
Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug‐resistant bacteria among COVID‐19 ICU patients from southwest Iran	100
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies	95
Comparison of model‐specific histopathology in mouse models of COVID‐19	94
Unrecognized introduction of SARS‐CoV‐2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent	89
Animal host range of mpox virus	87
Effect of the coronavirus pandemic on tumor markers	84
Emerging concerns regarding COVID‐19; second wave and new variant	84
Early warning signals for Omicron outbreaks in China: A retrospective study	81
Cell pyroptosis in picornavirus and its potential for treating viral infection	81
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis	80
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients	79
National trends in physical activity among adolescents in South Korea before and during the COVID‐19 pandemic, 2009−2021	79
Impaired systemic nucleocapsid antigen clearance in severe COVID‐19	76
Evaluation of the relationship between KIM‐1 and suPAR levels and clinical severity in COVID‐19 patients: A different perspective on suPAR	75
Relative telomere length impact on mortality of COVID‐19: Sex differences	74
Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion	74
Anal and oropharyngeal HPV distribution in HIV‐negative multipartner MSM using self‐sampling kits for HIV and sexually transmitted infection screening	73
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China	73
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico	71
Viral load: We need a new look at an old problem?	70
CRISPR dual enzyme cleavage triggers DNA and RNA substrate cleavage for SARS‐CoV‐2 dual gene detection	69
Covid associated immune dysfunction (CAID) leading to increased pediatric hospitalizations	68
Previous SARS‐CoV‐2 infection is linked to lower vaccination intentions	67
Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China	67
Prevalence of human papillomavirus (HPV) in oral mucosal lesions in Iran: A systematic review and meta‐analysis	66
Hypoxia and hypoxia‐inducible factors in Kaposi sarcoma‐associated herpesvirus infection and disease pathogenesis	66
Antibiotics in COVID‐19: Unveiling disturbing truths through critical scrutiny	66
Exploring free amino acid profiles in Crimean‐Congo hemorrhagic fever patients: Implications for disease progression	66
Head‐to‐head comparison of genotyping of human papillomavirus by real‐time multiplex PCR assay using type‐specific primers and SPF10‐PCR‐based line probe assay	65
Immune landscape of viral cancers: Insights from single‐cell sequencing	64
HBsAg (−)/HBsAb (−)/HBeAg (−)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B‐cell lymphoma receiving rituximab based immunochemotherapy	64
European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test	63
TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population	63
Emerging Pteropine orthoreoviruses and their potential impact on public health	63
Exploring the mechanisms of long COVID: Insights from computational analysis of SARS‐CoV‐2 gene expression and symptom associations	62
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection	62
Medium‐term serostatus in Spanish case series recovered from SARS‐CoV‐2 infection	61
Elements of Th1/Th2 response and disease severity in COVID‐19 patients: A short report	61
Machine learning‐driven blood transcriptome‐based discovery of SARS‐CoV‐2 specific severity biomarkers	61
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV	61
Long‐term dynamic shifts in genomic base content and evolutionary trajectories of SARS‐CoV‐2 variants	61
The modified COVID‐19 Yorkshire Rehabilitation Scale (C19‐YRSm) patient‐reported outcome measure for Long Covid or Post‐COVID‐19 syndrome	61
COVID‐19 sniffer dog experimental training: Which protocol and which implications for reliable sidentification?	59
The risk assessment of uveitis after COVID‐19 diagnosis: A multicenter population‐based study	58

First detection of SARS‐CoV‐2 BA.2.86.1 in Italy	58
Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma	58
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity	58
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID‐19 pneumonia	57
The variants question: What is the problem?	57
Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–2021	57
The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021	56
Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study	56
Unveiling the role of KSHV‐infected human mesenchymal stem cells in Kaposi's sarcoma initiation	56
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial	55
Gut microbiota dysbiosis associated with plasma levels of Interferon‐γ and viral load in patients with acute hepatitis E infection	55
Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens	55
Increased population susceptibility to seasonal influenza during the COVID‐19 pandemic in China and the United States	55
First detection of multiple cases related to CV‐A16 strain of B1c clade in Beijing in 2022	55
No signs of “tripledemic” in Finnish children	55
Genotyping and traceability analysis of norovirus in Yantai between 2017 and 2019	53
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection	53
An outbreak of a novel lineage of dengue virus 2 in Vietnam in 2022	51
QuantiFERON‐CMV and monitor predict cytomegalovirus, mortality, and graft‐versus‐host disease in transplant recipients	51
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping	50
Live‐virus serum neutralization after bivalent SARS‐CoV‐2 mRNA vaccination in hemodialysis patients	50
Sequencing on an imported case in China of COVID‐19 Delta variant emerging from India in a cargo ship in Zhoushan, China	50
Strong association of functional polymorphism in IL‐12B with susceptibility to chronic hepatitis B in Tunisia	50
Evolution trace of SARS‐CoV‐2 from January 19 to March 12, 2020, in the United States	50
Exploring viral infections' role in Kawasaki disease onset: A study during the COVID‐19 pandemic	49
Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT‐PCR for SARS‐CoV‐2	48
Cross‐immunity and trained immunity in explaining variable COVID‐19 mortality—Guidance for future pandemics	48
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic	48
Retrospective investigation of overlooked Mpox virus infection in saliva samples from patients with suspected syphilis in Japan	48
Risk stratification for cervical precancer and cancer by DH3‐HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study	48
Peripheral blood parameters for predicting PICU admission and mechanical ventilation in pediatric inpatients with human parainfluenza virus‐induced pneumonia	47
Α case of seronegative autoimmune encephalitis associated with human herpesvirus‐7 (HHV‐7)	47
Molecular epidemiology and risk factors associated with BK and JC polyomavirus urinary shedding after kidney allograft	47
The origin and spread of HIV‐1 CRF59_01B epidemic in China: A molecular network and phylogeographic analysis	47
Immune‐dysregulation in subacute sclerosing panencephalitis: An exploratory case–control study	46
Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave	46
Epidemiology of the resurgence of respiratory syncytial virus infections among children post‐COVID‐19: A single‐center retrospective observational study	46
Reactivation or reinfection of COVID‑19 disease?	46
Discovery of a small‐molecule inhibitor targeting the ovarian tumor domain of a novel Tamdy orthonairoviruse associated with human febrile illness	45
Tracking down B.1.351 SARS‐CoV‐2 variant in Pakistan through genomic surveillance	45
Genetic predisposition to blood cell indices in relation to severe COVID‐19	45
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries	45
Comment on Higashimoto et al. “Analysis of the reliability of rapid diagnostic tests for varicella, including breakthrough cases”	44
Mpox in the New York metropolitan area, Summer 2022	44
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults	44
Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases	43
Postvaccination SARS‐CoV‐2 Alpha (B.1.1.7) lineage infection among healthcare workers on the background of IgG antibodies	43
Novel mutations in antiviral multiresistant HSV‐2 genital lesion: A case report	43
Genome‐based survey of the SARS‐CoV‐2 BF.7 variant from Asia	42
First wave of COVID‐19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases	41
Epidemiology of cytomegalovirus infection in pregnancy in Israel: Real‐world data from a large healthcare organization	41
The evaluation of potential global impact of the N501Y mutation in SARS‐COV‐2 positive patients	40
Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA‐mutant cervical carcinoma via the PI3K/AKT pathway	40
Comparison of epidemiological characteristics between hemorrhagic fever with renal syndrome patients and severe fever with thrombocytopenia syndrome patients	40
Severe influenza virus infection in children admitted to the PICU: Comparison of influenza A and influenza B virus infection	40
Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city	40
Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV‐1 from Guangzhou, China	40
Distribution of cervical intraepithelial neoplasia is closely associated with HPV status and uterine position	40
Better detection of Torque teno virus in children with leukemia by metagenomic sequencing than by quantitative PCR	40
Mapping variants in HTLV‐1 genome to analyze their impacts on the HAM/TSP development: A systematic review	39
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients	39
The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi‐institutional propensity score‐matched cohort study	39
What is the true place of the SARS‐CoV‐2 rapid point‐of‐care antigen test in the hospital setting? Lessons learned from real life	39
Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips	39
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review	39
Evaluation of the late presentation and associated factors of people living with HIV in Turkey	39
Evaluation of childhood hospitalization rates and degree of severity of SARS‐CoV‐2 variants, including B.1.1.7 (Alpha), B.1.315/P.1 (Beta/Gamma), and B.1.617.2 (Delta)	38
COVID‐19db linkage maps of cell surface proteins and transcription factors in immune cells	38
Relationship between SARS‐CoV‐2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Paraná, Brazil	38
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort	38
Mutational and phylogenetic analyses of the two lineages of the Omicron variant	38
Prognostic significance of plasma cytomegalovirus (CMV) DNA load in immunocompetent patients with CMV pneumonia: A retrospective cohort study	38
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID‐19 epidemic in Wuhan, China	38
Burden and seasonality of RSV bronchiolitis in hospitalized children on a French Caribbean island: Practical lessons from a 13‐year study	37
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading	37
Comparison of effectiveness and cost of different HCV testing strategies in high‐risk populations in China	37
Plasma vitamin D levels are correlated with the pathogenesis of human T‐cell leukemia virus type 1‐associated diseases	37
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials	37
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study	36
Obesity's Unexpected Influence: Reduced Alphavirus Transmission and Altered Immune Activation in the Vector	36

Divergent autoantibody and cytokine levels in COVID‐19 sepsis patients influence survival	36
A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine	36
Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department	36
The acceptance of SARS‐CoV‐2 rapid antigen self‐testing: A cross‐sectional study in China	36
Antibody‐dependent NK‐cell and neutralizing antibody responses against the Spike protein of Wuhan‐Hu‐1 and Omicron BA.1 SARS‐CoV‐2 variants in vaccinated experienced and vaccinated naïve individuals	36
Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes	36
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used	35
Identification of a new 2‐amino acid insertion in the integrase coding region of HIV‐1 subtype G isolates	35
Causal association of the brain structure with the susceptibility, hospitalization, and severity of COVID‐19: A large‐scale genetic correlation study	35
Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV‐infected patients on antiretroviral therapy	35
What is the real sword of HBV precore and basal core promoter mutations piercing the hepatocyte homeostasis: HBcAg or HBsAg?	35
Herpes simplex virus and SLE: Though uncommon yet with significant implications	34
Unreliable predictions about COVID‐19 infections and hospitalizations make people worry: The case of Italy	34
Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping	34
Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern	34
Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet	34
Development of a unit conversion tool for five quantitative anti‐spike assays and agreement analysis of three qualitative anti‐nucleocapsid assays for SARS‐CoV‐2	34
Single‐tube, single‐strip lateral flow assays utilizing loop‐mediated isothermal amplification for simultaneous hepatitis B and C viral detection	34
Different species of Chiroptera: Immune cells and molecules	34
On the severity of COVID‐19 infections in 2021 in Italy	33
Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies	33
Proximity ligation‐based sequencing for the identification of human papillomavirus genomic integration sites in formalin‐fixed paraffin embedded oropharyngeal squamous cell carcinomas	33
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India	33
Development of a CRISPR/Cas12a‐recombinase polymerase amplification assay for visual and highly specific identification of the Congo Basin and West African strains of mpox virus	33
Antiviral therapy in DRESS	33
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains	33
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections	33
Maximal temperature varies by sex and ethnic group in hospital in‐patients with Covid‐19 infection	33
Oxidative stress and decreased Nrf2 level in pediatric patients with COVID‐19	32
Downregulation of type III interferons in patients with severe COVID‐19	32
Association between the HLA genotype and the severity of COVID‐19 infection among South Asians	32
Coronavirus disease 2019 (COVID‐19): A systematic review of 133 Children that presented with Kawasaki‐like multisystem inflammatory syndrome	32
Traceability of SARS‐CoV‐2 transmission through quasispecies analysis	32
Epidemiological and clinical characteristics of adenovirus‐associated respiratory tract infection in children in Hangzhou, China, 2019−2024	32
Molecular characterization of HTLV‐1 genomic region hbz from patients with different clinical conditions	32
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model	32
G‐quadruplex ligands inhibit chikungunya virus replication	32
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy	32
NAC1 confines virus‐specific memory formation of CD4+ T cells through the ROCK1‐mediated pathway	32
Real‐life evaluation of a rapid extraction‐free SARS‐CoV‐2 RT‐PCR assay (COVID‐19 PCR Fast‐L) for the diagnosis of COVID‐19	32
Epidemiological Characteristics of Neuro‐Specific Antibodies Following Viral Infections	32
Long‐Term Infection With a Particular Human Papillomavirus (HPV) Genotype, HPV Subtype, or HPV Genomic Variant Does not Significantly Influence the Clinical Course of Recurrent Respiratory Papillomato	31
First Confirmed Report of Jamestown Canyon Virus in Greenland	31
Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview	31
COVID‐19 vaccination and decreased death rates: A county‐level study in Pennsylvania	31
Systematic review and meta‐analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS‐C) associated with SARS‐CoV‐2 infection	31
Back Cover Image, Volume 95, Number 6, June 2023	31
Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers	31
Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city	31
Creating an ultra‐sensitive detection platform for monkeypox virus DNA based on CRISPR technology	30
Human immunodeficiency virus: The potential of medicinal plants as antiretroviral therapy	30
Remdesivir significantly reduces SARS‐CoV‐2 viral load on nasopharyngeal swabs in hospitalized patients with COVID‐19: A retrospective case–control study	30
COVID‐19: A new risk factor or just a new imitator of preeclampsia? NLRP3 activation: A possible common mechanism	30
Food for thought: Eating before saliva collection and interference with SARS‐CoV‐2 detection	30
Low antibody levels associated with significantly increased rate of SARS‐CoV‐2 infection in a highly vaccinated population from the US National Basketball Association	30
A cross‐sectional study of SARS‐CoV‐2 seropositivity among healthcare workers and residents of long‐term facilities in Italy, January 2021	30
The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients	30
Early initiation of the respiratory syncytial virus season in 2021–2022, Greece	29
Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) after COVID‐19 infection or vaccination	29
Immunogenicity and safety of inactivated SARS‐CoV‐2 vaccines in people living with HIV: A longitudinal cohort study	29
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples	29
Assessing risk factors for COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease	29
Disinfection and decontamination in the context of SARS‐CoV‐2‐specific data	29
Polymorphisms of RIG‐I‐like receptor influence HBV clearance in Chinese Han population	29
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial	29
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond	29
Respiratory torque teno virus load at emergency department visit predicts intensive care unit admission of SARS‐CoV‐2 infected patients	29
SARS‐CoV‐2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species	29
Cover Image, Volume 94, Number 10, October 2022	28
Bioinformatics analysis of the s2m mutations within the SARS‐CoV‐2 Omicron lineages	28
Eliminating cervical cancer in China: Opportunities come and challenges remain	28
SARS‐CoV‐2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods	28
MORC3 restricts human cytomegalovirus infection by suppressing the major immediate‐early promoter activity	28
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children	28
Coverage of Japanese encephalitis routine vaccination among children in central India	28
“Olfactory dysfunction in COVID‐19, new insights from a cohort of 353 patients: The ANOSVID study”: Author's reply	28
Prevalence of drug resistant HIV‐1 forms in patients without any history of antiretroviral therapy in the Republic of Guinea	28
Emerging global concern of Langya henipavirus: Pathogenicity, virulence, genomic features, and future perspectives	28
The whole‐genome sequencing of prevalent DENV‐1 strains during the largest dengue virus outbreak in Xishuangbanna Dai autonomous prefecture in 2019	28
Evaluating agreement in different diagnosis methods is necessary	28
Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination	28
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study	28
Modulation of cellular machineries by Zika virus‐encoded proteins	27
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”	27
Rapid decrease of nasopharyngeal SARS‐CoV‐2 antigen in an outbreak of the Omicron strain	27
Molecular evolution and antigenic drift of type 3 iVDPVs excreted from a patient with immunodeficiency in Ningxia, China	27
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor	27
Resistance‐associated mutations to the anti‐SARS‐CoV‐2 agent nirmatrelvir: Selection not induction	27
Does ACE2 mediate the detrimental effect of exposures related to COVID‐19 risk: A Mendelian randomization investigation	27
Comments on Rahmati et al., The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis. J Med Virol. 2022; 1	27
Effect of inactivated vaccine boosters against severe and critical COVID‐19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China	27
A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super‐enhancers in maintaining EBV latency	26
A pyrosequencing protocol for rapid identification of SARS‐CoV‐2 variants	26
High detection rate of viral pathogens in nasal discharge in children aged 0 till 5 years	26
	26